A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults (NCT07171164) | Clinical Trial Compass
RecruitingNot Applicable
A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults
United States750 participantsStarted 2025-09-10
Plain-language summary
In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2) encourage younger adults to discuss RSV vaccination with their older friends and family members (Activate phase).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Motivate Aim Inclusion Criteria:
* Age 50 years or older
* Self-identify as Latino/a/x and/or indigenous groups from Latin America
* Eligible for RSV vaccination per current CDC/ACIP recommendations
* Fluent in Spanish or English
* Has not received the RSV vaccine
* Has a cell phone
* Lives or works in San Francisco or Daly City
* Able to provide informed consent
Motivate Aim Exclusion Criteria:
* Intent to move outside of San Francisco or Daly City in the next year
* Nursing home resident
* Household member participating in Aim 1 or 2
* Unable to provide consent
Motivate Aim Inclusion Criteria:
* Age 18-49 years
* Self-identify as Latino/a/x and/or indigenous groups from Latin America
* Fluent in English or Spanish
* Has \>1 family member or friend 50 years or older who they have seen or spoken to for \>15 minutes in the last 6 months and who lives in the United States
Activate Trial Exclusion Criteria:
* Household member enrolled in Aim 1 or 2
* Unable to provide consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Motivate Aim Primary Outcome - RSV Vaccine Uptake
Timeframe: 60 days from study enrollment
2
Activate Aim Primary Outcome - Proportion of Contacts with whom RSV Vaccination Discussed